266 related articles for article (PubMed ID: 15028447)
1. Prostate cancer diagnosed in spinal cord-injured patients is more commonly advanced stage than in able-bodied patients.
Scott PA; Perkash I; Mode D; Wolfe VA; Terris MK
Urology; 2004 Mar; 63(3):509-12. PubMed ID: 15028447
[TBL] [Abstract][Full Text] [Related]
2. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment for prostate cancer in patients with prior spinal cord injury.
Gammon SR; Berni KC; Virgo KS; Johnson FE
Ann Surg Oncol; 2005 Aug; 12(8):674-8. PubMed ID: 15968495
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database.
White WM; Sadetsky N; Waters WB; Carroll PR; Litwin MS
J Urol; 2008 Dec; 180(6):2409-13; discussion 2414. PubMed ID: 18930270
[TBL] [Abstract][Full Text] [Related]
6. Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus.
Levinson A; Nagler EA; Lowe FC
Urology; 2005 Jan; 65(1):91-4. PubMed ID: 15667871
[TBL] [Abstract][Full Text] [Related]
7. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
[TBL] [Abstract][Full Text] [Related]
8. Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study.
Sato N; Akakura K; Isaka S; Nakatsu H; Tanaka M; Ito H; Masai M;
Urology; 2004 Aug; 64(2):341-5. PubMed ID: 15302491
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan.
Hachiya T; Akakura K; Saito S; Shinohara N; Sato K; Harada M; Kato T; Okada K
BJU Int; 2005 Mar; 95(4):534-40. PubMed ID: 15705075
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of prostate cancer in patients with chronic spinal cord injury.
Patel N; Ngo K; Hastings J; Ketchum N; Sepahpanah F
PM R; 2011 Jul; 3(7):633-6. PubMed ID: 21777862
[TBL] [Abstract][Full Text] [Related]
11. Prostate carcinoma among men with human immunodeficiency virus infection.
Crum NF; Spencer CR; Amling CL
Cancer; 2004 Jul; 101(2):294-9. PubMed ID: 15241826
[TBL] [Abstract][Full Text] [Related]
12. [Adenocarcinoma of prostate in men younger than 50--rectal palpation mandatory with micturition problems].
Wymenga LF; Mensink HJ
Ned Tijdschr Geneeskd; 2001 Mar; 145(12):553-7. PubMed ID: 11293992
[TBL] [Abstract][Full Text] [Related]
13. Prostate growth and prevalence of prostate diseases in early onset spinal cord injuries.
Bartoletti R; Gavazzi A; Cai T; Mondaini N; Morelli A; Del Popolo G; Geppetti P
Eur Urol; 2009 Jul; 56(1):142-8. PubMed ID: 18280636
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up.
Akaza H; Homma Y; Usami M; Hirao Y; Tsushima T; Okada K; Yokoyama M; Ohashi Y; Aso Y;
BJU Int; 2006 Sep; 98(3):573-9. PubMed ID: 16925756
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional survey of long-term quality of life after radical perineal prostatectomy.
Yang BK; Crisci A; Young MD; Silverstein AD; Peterson BL; Dahm P
Urology; 2005 Jan; 65(1):120-5. PubMed ID: 15667876
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer update: 2005.
Ryan CJ; Small EJ
Curr Opin Oncol; 2006 May; 18(3):284-8. PubMed ID: 16552242
[TBL] [Abstract][Full Text] [Related]
17. Prostate brachytherapy: a descriptive analysis from CaPSURE.
Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
[TBL] [Abstract][Full Text] [Related]
18. The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment.
Mettlin CJ; Murphy GP; Cunningham MP; Menck HR
Cancer; 1997 Oct; 80(7):1261-6. PubMed ID: 9317177
[TBL] [Abstract][Full Text] [Related]
19. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
20. Prostate activity and prostate cancer in spinal cord injury.
Shim HB; Jung TY; Lee JK; Ku JH
Prostate Cancer Prostatic Dis; 2006; 9(2):115-20. PubMed ID: 16534510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
